Biogen

denovirus transmission replication treatments 3D scientific illustration
Biotech

Biogen discontinues all AAV gene therapy work

While most of the team members that had focused on AAV capsids were reassigned to other roles, a small number of employees were laid off.
Gabrielle Masson Sep 26, 2025 11:04am
pass the torch deal sell buy acquisition

Biogen inks $85M Alcyone buyout to acquire drug delivery tech

Sep 18, 2025 10:30am
spinraza

Biogen to take Spinraza follow-up into registrational studies

Jun 25, 2025 8:04am
blueprint city rendering

Biogen blueprints $1B CNS deal with RNAi biotech

May 27, 2025 10:55am
Glowing puzzle piece fitting into puzzle

Biogen pays Stoke $165M, bagging Dravet drug to fire up pipeline

Feb 18, 2025 9:28am
Photo of an ax atop a pile of three logs

Biogen axes asset from $7.3B buyout, plus Alzheimer’s prospect

Feb 12, 2025 9:53am